|Bid||47.06 x 100|
|Ask||49.50 x 200|
|Day's Range||48.29 - 48.51|
|52 Week Range||36.81 - 50.24|
|PE Ratio (TTM)||11.72|
|Dividend & Yield||1.64 (3.40%)|
|1y Target Est||N/A|
Janus Henderson lists the world's biggest dividend payers. Take a look at the yield on some of these NYSE listed shares. Double your Treasury bond.
Regeneron Pharmaceuticals has a slew of clinical trials going on, and studies evaluating REGN-2810 could be the most important.
Analysts at Argus no longer hold a bullish view on Mylan N.V. (NASDAQ: MYL ) after the company cut its full-year guidance and cautioned that its earnings per share will decline in 2017. The firm's Jasper ...